Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

http://www.wikidata.org/entity/Q34769550

about

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Is there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for neuroprotective neuronal transcriptional programs Neuroinflammation in Alzheimer's disease Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis.Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus.CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients.Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.Exosomal biomarkers in Down syndrome and Alzheimer's disease.Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients.A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.Alzheimer's Disease, Oligomers, and Inflammation.Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.

P2860

Q26774743-D3673709-B081-4C86-B3F7-4504FBBF5B45 Q26996617-7A678207-881C-4D09-A285-BFE38B807122 Q27004226-23A7A8A3-06DE-4315-ACAA-AD15968CC614 Q33603633-00AEB8CE-7BDE-49ED-8254-F71AC402F06E Q34475359-92D79527-E217-4B97-B983-A02237720E0C Q35812498-40CD0476-FF9D-4973-AE91-5A26D5DAC5A9 Q36595660-53D8B567-1E45-4570-BAD3-D8A7A90A37B2 Q38543843-9C55C8F5-D5F4-4B2F-B215-AC8F514B506F Q38574670-C8031249-B1FB-40C2-9F68-7E2782E09EA8 Q38693438-DAA66F07-5FDA-4ACB-8425-D352C1C33B9F Q38836004-871BF28B-2457-4B2F-8861-58B7B21BB2D0 Q39447009-39F70A4A-6646-40DF-B17E-1FFFBE4B0988 Q40507310-EC767E40-1353-4F12-86AA-9FAED1AB51C4 Q41942395-CAFB3F55-F0F2-4274-AEE3-5808F1E37327 Q42364364-F3D23CA7-5B0E-4ACA-9250-1794EB6DD102 Q44801837-23B7AB2D-E71C-48E3-8064-0B1BD76EC1C4 Q47213450-6EE9F7F6-0980-467D-9661-2CB16408959E Q47830428-F636C9E4-42BD-4602-8F1B-ED7B0BE9D4C1 Q47926820-F13D0D98-F066-47DF-A0CA-607B72AC5CF5 Q47960190-DBF917DD-F6BA-4856-A9E9-BB224045365C Q50034510-78151CF9-C882-4BCF-9AEA-6A8E05AE85D1 Q50553594-FFA21C63-B2E2-478E-AC1C-8BAE11212AB9 Q50655925-821B846F-CD41-44EF-AC1B-7884029A1E30 Q50864602-859FACE4-A496-404B-8E2D-AE4F3073FB6B Q51760887-7527C6EE-F812-4BEF-9650-537A7819625D Q51760901-8B937E72-1392-435B-AC72-28D9062737FD Q52644596-93D13CE4-FF89-458A-BACD-A4A8A51C93F5 Q55071408-057E8BCB-A0DF-4668-AA72-64921929710C

P2860

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

http://www.wikidata.org/entity/Q34769550

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@ast

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@en

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@nl

type

label

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@ast

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@en

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@nl

prefLabel

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@ast

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@en

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@nl

P1433

Q34769550-78196E0C-5D87-436C-A739-44A51BD602BE

P1476

Q34769550-F3E7316C-1418-427A-8C7C-36F02A7A3923

P2093

Q34769550-84BE8D67-5236-45F0-B2C6-70FC9E1301C5

Q34769550-A9587E4A-CFCB-4938-B714-A361F9E5E247

Q34769550-AB3240CA-C2C0-4622-B2A5-F25A99422EC3

Q34769550-B58C8282-5DD8-4550-9E86-484FE43276B1

P2860

Q34769550-0717529D-2BA7-45C9-A66F-DDBFC5DA5ADC

Q34769550-08985893-E59F-4FE1-A2FD-5F380D760407

Q34769550-091E1B98-CD41-4EF9-B0B1-B087B09C0B22

Q34769550-1009CBF8-07AA-41FC-85D7-C02616600911

Q34769550-1145C8C8-D08C-4D0C-9D4D-DBF0AA3DCD25

Q34769550-14ABA60C-1417-432A-8A94-F853FBDD3FDD

Q34769550-1E66934B-CD3A-429A-B127-84E1225F10F8

Q34769550-410273AF-9E49-44D6-9D67-268F9FE93C26

Q34769550-4421128B-C535-41E5-95F8-615734E1322D

Q34769550-487A08DF-88E0-4CE1-BF96-96CDA35F6FDD

P304

Q34769550-E6C5171D-6B3B-43DD-BCF7-2193F51D2D77

P31

Q34769550-A1573765-8FD3-48E7-ADED-9991FE9890B6

P356

Q34769550-EEC25C6A-80CE-43EC-B0BA-F5C5AA6CE2AE

P407

Q34769550-3BF6AC69-2C4B-402F-B5B0-D448BD637D3B

P433

Q34769550-DF9BE2FC-0CC0-40E3-A8BF-8D84A09A8347

P478

Q34769550-5531E0B3-412B-49BD-9B70-C5DE1A997175

P50

Q34769550-0CFF2716-215D-47BD-A3E6-425355D740C9

Q34769550-32AB2C41-A29F-48F6-977F-F830468DC42C

Q34769550-5504031C-9124-4F98-B22A-8822807FD77A

Q34769550-999E223B-461E-4C4C-859D-8E59497731C6

Q34769550-ACD16CB2-09FC-4721-8849-DF3EBD87C60D

Q34769550-CAE18BC0-38D1-4136-A405-40752B1DC0E7

Q34769550-D6E3698D-0BAD-4F54-81D4-44AD40D62CF5

Q34769550-E83DD9F7-FC2D-4F6F-A467-39AFB780BEFF

Q34769550-EC24A7EA-C6D7-43EF-AB59-47F8A661D936

Q34769550-FB7DA6D0-251D-4F72-AEB0-C51C7D04EB81

P577

Q34769550-B5F22E1E-5056-442C-9D94-4B79BB0F099B

P5875

Q34769550-366A547D-4179-472F-9EB3-06145B42C9A0

P698

Q34769550-F70A291D-B5C9-4171-8F35-62AA43A2EF75

P921

Q34769550-C68D9A21-EA1F-41D6-93E1-01D4DDC1B024

Q34769550-F4619685-1AA6-4624-AC64-4889058BB308

P932

Q34769550-E373382C-21EA-440D-ADB0-498F32AD925E

P356

JOURNAL.PONE.0064971

P1433

P1476

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

@en

P2093

Andreas Güntert

http://www.w3.org/2001/XMLSchema#string

Andrew Simmons

http://www.w3.org/2001/XMLSchema#string

Lars-Olaf Wahlund

http://www.w3.org/2001/XMLSchema#string

Rufina Leung

http://www.w3.org/2001/XMLSchema#string

P2860

Role of imaging techniques in the diagnosis of dementia

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Inflammation and Alzheimer's disease

Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.

Cytokine-induced sickness behaviour: mechanisms and implications.

The significance of neuroinflammation in understanding Alzheimer's disease.

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Neuroimaging and early diagnosis of Alzheimer disease: a look to the future.

Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes.

P304

e64971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0064971

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Iwona Kłoszewska

Hilkka Soininen

Patrizia Mecocci

Petroula Proitsi

Deborah Kronenberg

Megan Pritchard

Magda N. Tsolaki

P577

2013-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237200560

http://www.w3.org/2001/XMLSchema#string

P698

23762274

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3677891

http://www.w3.org/2001/XMLSchema#string